Study Title: A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153
 

• Open to Accrual at:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Masonic Cancer Center, University of Minnesota
  • Fred & Pamela Buffett Cancer Center (University of Nebraska)
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
  • Penn State Cancer Institute
  • Rutgers Cancer Institute of New Jersey
  • Moffitt Cancer Center
  • Providence Health & Services – Oregon
  • University of Virginia
  • Virginia Commonwealth University
• Learn more:
  • clinicaltrials.gov: NCT04317534
  • Big Ten CRC News Release
• Publications and Presentations:
  • Trials in Progress: 2024 ASCO Annual Meeting
  • Poster Session: 2021 ASCO Annual Meeting

Study Contact: studies@hoosiercancer.org; (317) 921-2050.